Previous close | 2.6200 |
Open | 2.6900 |
Bid | 2.6600 x 800 |
Ask | 2.6900 x 2200 |
Day's range | 2.5500 - 2.7400 |
52-week range | 1.4050 - 3.4000 |
Volume | |
Avg. volume | 66,378 |
Market cap | 193.079M |
Beta (5Y monthly) | 1.10 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.8800 |
Earnings date | 08 May 2023 - 12 May 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 4.75 |
Ovid Therapeutics ( NASDAQ:OVID ) Full Year 2022 Results Key Financial Results Net loss: US$54.2m (down by 145% from...
If you want to know who really controls Ovid Therapeutics Inc. ( NASDAQ:OVID ), then you'll have to look at the makeup...
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...